Diagnostic 131I whole-body scintigraphy 1 year after thyroablative therapy in patients with differentiated thyroid cancer: correlation of results to the individual risk …
F Berger, U Friedrich, P Knesewitsch… - European journal of …, 2011 - Springer
Purpose 131 I whole-body scan (WBS) and serum thyroglobulin (TG) are important in
detecting thyroid remnants or recurrent disease in patients with differentiated thyroid cancer …
detecting thyroid remnants or recurrent disease in patients with differentiated thyroid cancer …
Evaluation of 131I scintigraphy and stimulated thyroglobulin levels in the follow up of patients with DTC: a retrospective analysis of 1420 patients
JM Gonzalez Carvalho, D Görlich, O Schober… - European Journal of …, 2017 - Springer
Aim To study the clinical yield of diagnostic whole body 131 I scintigraphy (DxWBS) in the
follow-up of differentiated thyroid carcinoma (DTC) patients in relation to stimulated …
follow-up of differentiated thyroid carcinoma (DTC) patients in relation to stimulated …
The role of routine diagnostic radioiodine whole-body scintigraphy in patients with high-risk differentiated thyroid cancer
SG de Meer, MR Vriens, PM Zelissen… - Journal of Nuclear …, 2011 - Soc Nuclear Med
Follow-up diagnostic radioiodine whole-body scintigraphy (DxWBS) is still advised for high-
risk patients with differentiated thyroid cancer. The aim of this study was to evaluate the …
risk patients with differentiated thyroid cancer. The aim of this study was to evaluate the …
Evaluation of^ sup 131^ I scintigraphy and stimulated thyroglobulin levels in the follow up of patients with DTC: a retrospective analysis of 1420 patients
JMG Carvalho, D Görlich, O Schober… - … Journal of Nuclear …, 2017 - search.proquest.com
Aim To study the clinical yield of diagnostic whole body 131I scintigraphy (DxWBS) in the
follow-up of differentiated thyroid carcinoma (DTC) patients in relation to stimulated …
follow-up of differentiated thyroid carcinoma (DTC) patients in relation to stimulated …
Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?
C Ma, J Xie, A Kuang - Journal of Nuclear Medicine, 2005 - Soc Nuclear Med
The long-term monitoring of patients with differentiated thyroid carcinoma (DTC) is essential
throughout the patient's life after total or nearly total thyroidectomy followed by 131I remnant …
throughout the patient's life after total or nearly total thyroidectomy followed by 131I remnant …
Thyrotropin variations may explain some positive radioiodine therapy scans in patients with negative diagnostic scans
P Zanotti-Fregonara, I Keller, D Rubello… - Journal of …, 2009 - Springer
Thyroglobulin (Tg) is a specific marker of residual thyroid cancer or tumor recurrence. In
patients with elevated Tg levels and negative diagnostic radioiodine (131 I) whole-body …
patients with elevated Tg levels and negative diagnostic radioiodine (131 I) whole-body …
Timing of post 131I ablation diagnostic whole body scan in differentiated thyroid cancer patients
M Winter, J Winter, A Heinzel… - Nuklearmedizin …, 2015 - thieme-connect.com
Aim: to determine whether the first three months after 131I ablation is too early to perform
radioiodine diagnostic whole body scintigraphy (dxWBS) in differentiated thyroid carcinoma …
radioiodine diagnostic whole body scintigraphy (dxWBS) in differentiated thyroid carcinoma …
Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole‐body …
M Salvatori, G Perotti, V Rufini… - Clinical …, 2004 - Wiley Online Library
Summary objective To evaluate the risk of performing inappropriate 131I ablative therapies
for thyroid carcinoma in patients lacking thyroid remnants or metastases, using a strategy of …
for thyroid carcinoma in patients lacking thyroid remnants or metastases, using a strategy of …
No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer
FA Verburg, MPM Stokkel, C Düren… - European journal of …, 2010 - Springer
Purpose To compare disease-specific survival and recurrence-free survival (RFS) after
successful 131 I ablation in patients with differentiated thyroid carcinoma (DTC) between …
successful 131 I ablation in patients with differentiated thyroid carcinoma (DTC) between …
Prognostic implication of thyroglobulin and quantified whole body scan after initial radioiodine therapy on early prediction of ablation and clinical response for the …
Objective To investigate predictors for successful ablation and disease-free status after high-
dose radioiodine therapy in patients with differentiated thyroid cancer. Methods We enrolled …
dose radioiodine therapy in patients with differentiated thyroid cancer. Methods We enrolled …